Insights from the East–West frontier.
Regulatory shifts, clinical strategy, market entry and talent — written for MedTech founders, leaders and operators.
RegulatoryNavigating HKMDD: A 2026 Roadmap for Listing Medical Devices in Hong Kong
The Hong Kong Medical Device Division's voluntary listing scheme remains the cleanest entry point into Asia for many MedTech innovators. Here is what to plan for in 2026.
Read article
Cross-BorderNMPA, TFDA, HKMDD Compared: Choosing Your First Asian Market Entry
Mainland China, Taiwan, and Hong Kong each offer a distinct entry profile. Picking the right first filing — and the right sequence — has more impact on your Asia P&L than most teams realise.
Read article
Clinical ResearchRunning Medical Device Clinical Trials in Hong Kong: PMCF, IRB and Site Strategy
Hong Kong offers a small but unusually high-quality clinical environment for medical device studies. Done well, an HK-anchored study can serve HKMDD, support a TFDA filing, and seed an NMPA narrative.
Read article
Market AccessFrom Approval to Adoption: Hospital Procurement Pathways Across APAC
Regulatory approval is the entry ticket; procurement is where revenue actually happens. Mapping the right tender, distributor, and KOL path per market is what turns a launch into a P&L.
Read article